Health Economics›NTRK›All lines of therapy

All lines of therapy

NTRK · 4 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

FiltersBiomarker

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Entrectinib monotherapy Variant #01	—	R 2 013 430	28d	—	—	—	—	—
Entrectinib monotherapy Variant #01	NTRK	R 2 013 430	28d	—	—	—	—	—
Larotrectinib monotherapy Variant #01 Partial	—	—	28d	—	—	—	—	—
Larotrectinib monotherapy Variant #01 Partial	NTRK	—	28d	—	—	—	—	—

4 of 4 regimens shown